期刊文献+

^1H-MRS鉴别乳腺良恶性病变的临床应用研究 被引量:2

暂未订购
导出
摘要 目的探讨MR氢质子波谱(1H-MRS)在乳腺良恶性病变鉴别诊断中的价值及其影响因素。方法回顾性分析经病理证实的67例乳腺肿瘤患者的1H-MRS表现,并与病理结果比较,其中乳腺癌39例,良性肿瘤28例,判断1H–MRS鉴别乳腺良恶性病变的价值。结果 39例乳腺癌22例出现胆碱(Choline,Cho)峰,28例良性肿瘤5例出现Cho峰。以出现Cho峰为恶性肿瘤诊断标准,其诊断的敏感性为56.4%,准确性为81.5%。结论1H-MRS对乳腺良恶性病变的鉴别有着重要的诊断意义。
出处 《中国医药指南》 2012年第29期85-86,共2页 Guide of China Medicine
基金 江门市科技局2010048
  • 相关文献

参考文献12

  • 1Aisen AM,Chenevert TL.MR Spectroscopy; Clinical Perspective [J].Radiology, 1989,173(3):593-599.
  • 2Bottomley PA .Human in-vivo NMR Spectroscopy in Diagnostic Medicine: Clinical Tool or Research Probe [J].Radiology,1989,170(1):l-15.
  • 3Kalra R,Wade KE,Hands L,et al .Phosphoumoester is Associated with Proliferation in Human Breast Cancer : a 31P-MRS Study [J].J Bri Cancer,1993,67(5):l145-11535.
  • 4Glunde K,Jie C,Bhujwalla ZM.Molecular Causes of the abberant choline phospholip id metabolism in breast cancer[J].Cancer Res,2004,64(12):4270-4276.
  • 5Katz - Brull R,Lavin PT,Lenkinski RE,et al.Clinical utility ofproton magnetic resonance spectroscopy in characterizing breast lesions[J].J Natl Cancer Inst,2002,94(16):1197-1203.
  • 6Bartella L,Morris EA,Dershaw DD,et al.Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis[J].Radiology,2006,239(3):686-692.
  • 7Stanwell P,Gluch L,Clark D,et al.Specificity of choline metabolites for in vivo diagnosis of breast cancer using tH-MRS at 1.5T[J].Eur Radiol,2005,15(5):1037-1043.
  • 8赵斌,蔡世峰,于台飞,彭洪娟,李慧华.MR氢质子波谱在乳腺肿块应用中的价值及技术干扰因素分析[J].中华放射学杂志,2006,40(3):281-284. 被引量:32
  • 9冯赟,刘士远,王晨光,蒋涛,陶晓峰,王金林,肖湘生.^1H—MRS在乳腺良恶性病变鉴别诊断中的价值[J].放射学实践,2008,23(6):611-614. 被引量:5
  • 10陈林丽,赵建农,郭大静.MR氢质子波谱在乳腺肿瘤中的临床应用价值[J].实用放射学杂志,2008,24(6):818-820. 被引量:6

二级参考文献52

  • 1赵斌,蔡世峰,于台飞,彭洪娟,李慧华.MR氢质子波谱在乳腺肿块应用中的价值及技术干扰因素分析[J].中华放射学杂志,2006,40(3):281-284. 被引量:32
  • 2Glunde K,Jie C, Bhujwalla ZM. Molecular Causes of the abberant choline phospholipid metabolism in breast cancer[ J ]. Cancer Res,2004, 64(12) :4270 -4276.
  • 3Katz - Brull R ,Lavln PT, Lenkinski RE, et al. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions [ J]. J Natl Cancer Inst,2002,94(16) :1197 - 1203.
  • 4Bartella L, Morris EA, Dershaw DD,et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis[ J ]. Radiology ,2006,239 ( 3 ) :686 - 692.
  • 5Stanwell P,Gluch L, Clark D, et al. Specificity of choline metabolites for in vivo diagnosis of breast cancer using ^1H MRS at 1.5T [ J ]. Eur Radiol,2005,15 ( 5 ) : 1037 - 1043.
  • 6Jacobs MA, Barker PB, Arqani P, et al. Combined dynamic contrast enhanced breast MR and proton spectroscopy imaging: a feasibility study[ J]. J MRI,2005,21 ( 1 ) : 23 -28.
  • 7Seenu V, Pavan Kumar MN, Sharma U, et al. Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer[ J ]. Magn Reson Imaging,2005,23 (10) : 1005 - 1010.
  • 8Jagannathan NR, Kumar M ,Seenu V, et al. Evaluation of total choline from in - vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer [J]. Br J Cancer,2001,84(8) : 1016 - 1022.
  • 9Wendie AB,Lorena G,Moriel SN,et al.Diagnostic accuracy of mammography,clinical examination,US,and MR imaging in preoperative assessment of breast cancer.Radiology,2004,233:830-849.
  • 10上海市疾病预防控制中心.2008年上海市恶性肿瘤报告.上海SCDC,2008,5:4-11.

共引文献46

同被引文献34

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部